March 2026
The global endotracheal tube market size was estimated at USD 2.19 billion in 2025 and is predicted to increase from USD 2.34 billion in 2026 to approximately USD 4.24 billion by 2035, expanding at a CAGR of 6.84% from 2026 to 2035.
Day by day, the world is facing a massive growth in diverse respiratory diseases, like asthma, COPD, and COVID-19, rising surgical procedures, and the surging emergencies are demanding advanced endotracheal tubes. Novelty has inclined towards antimicrobial coatings, sensor-based technologies, and pediatric measures.
Firstly, the use of a flexible plastic, single-use tube inserted through the mouth or nose into the trachea to keep an open airway and deliver oxygen, often linked to a ventilator, is referred to as the endotracheal tube market. It has wider applications during surgeries, emergency medicine, or ICU care for patients who are facing difficulty in breathing on their own. Its widespread adoption is mainly propelled by increasing respiratory diseases, like COPD, asthma, COVID-19, the geriatric population, & growing surgical procedures, which need anesthesia.
.webp "Approximate Cases Per Year (In Million)")
A very prominent advancement in the endotracheal tube is AI-enabled Videolaryngoscopy (VL), such as larynGuide & Frontier’s motorized VL, which leverages computer vision to find anatomical structures in real-time, & finally supports clinicians with navigation. The market has been spurring new technologies, including the Kepler Intubation System (KIS) & Remote Robot-Assisted Intubation System (RRAIS), for autonomous or semi-autonomous, quicker, and more precise tube placement.
Firms are actively encouraging the reduction of VAP by employing antimicrobial-coated tubes, like AgION antimicrobial surface & specialized, subglottic secretion suctioning channels.
Several manufacturers are transitioning towards thinner, stronger, and more flexible materials to facilitate excellent sealing, minimal mucosal injury, and better, more persistent performance.
Researchers are putting efforts into sensors that offer consistent, real-time feedback to maintain correct cuff pressure (20–30 cmH₂O) automatically, which will mitigate tracheal necrosis or aspiration.
| Table | Scope |
| Market Size in 2026 | USD 2.34 Billion |
| Projected Market Size in 2035 | USD 4.24 Billion |
| CAGR (2026 - 2035) | 6.84% |
| Leading Region | North America by 38% |
| Historical Data | 2020 - 2023 |
| Base Year | 2025 |
| Forecast Period | 2026 - 2035 |
| Measurable Values | USD Millions/Units/Volume |
| Market Segmentation | By Product, By Route, By Application, By End Use, By Region |
| Top Key Players | Angiplast Pvt Ltd, Advin Health Care, Sterimed Group, ICU Medical, Inc., Medtronic (Covidien), Van Oostveen Medical B.V., Teleflex Incorporated, Convatec Inc., Fuji Systems Corp, SEWOON MEDICAL Co., Ltd. |
Which Product Dominated the Endotracheal Tube Market in 2025?
In 2025, the regular endotracheal tube segment held a major revenue share of the market by 44%. Globally surging demand for elective and emergency surgeries, which requires constant use of standard ETTs. Also, this type of tube is preferred in emerging areas, as it is cost-effective compared to advanced, coated, or specialized variants. They are usually developed by using soft, thermo-sensitive materials that conform to the patient's anatomy for increased comfort & better fit.
Reinforced Endotracheal Tube
Moreover, the reinforced endotracheal tube segment is predicted to expand fastest. This plays a vital role in preventing kinking/compression during neurosurgery, prone positioning, or head/neck surgeries. The trend is focusing on the progression of titanium-alloy helical wire-reinforced tubes, which enable safe use during magnetic resonance imaging, eliminating the heating and artifact concerns of traditional stainless steel. Specialized designs, like reinforced rescue tubes, are coupled with laryngeal mask airways (LMAs), & they offer flexible construction & specialized connectors for difficult airways.
How did the Orotracheal Segment Lead the Endotracheal Tube Market in 2025?
The orotracheal segment captured the largest share of the market by 76% in 2025 and is anticipated to expand at a rapid CAGR. Its dominance is fueled by its priority in emergencies, trauma, and anesthesia due to its pace and ease of placement compared to other routes. Surgeons are implementing specialized bougies & stylets to enhance speed and success in difficult conditions. This route overcomes nasal bleeding, sinus infections, and damage to turbinates.
Why did the Emergency Treatment Segment Dominate the Market in 2025?
In 2025, the emergency treatment segment held the biggest share of the market by 48% and is estimated to witness rapid growth. The globally accelerating number of accidents and injuries, with other cardiovascular and orthopedic issues, is driving the need for rapid, reliable airway management and general anesthesia, which relies on ETTs. The era is aiming at rising first-pass success rates (FPS), boosting oxygenation during the procedure, and lowering complications, such as esophageal intubation & hypoxia.
Which End Use Led the Endotracheal Tube Market in 2025?
The hospitals segment registered dominance in the market by 42% in 2025. Hospitals hold a high-volume ICU, emergency, and surgical requirements, which fuel demand for these endotracheal tubes. Hospitals are widely using double-lumen tubes for independent lung ventilation during thoracic surgery, or armored tubes that avoid kinking in head & neck surgeries. Alongside, hospitals are encouraging subglottic secretion drainage (SSD-ETT), which minimizes the risk of ventilator-associated pneumonia (VAP) and the requirement for or time spent on mechanical ventilation.
Clinics
Furthermore, the clinics segment is predicted to expand rapidly. Clinics are increasingly using an endotracheal tube in the operating room (OR) to manage the airway and in the ICU for prolonged mechanical ventilation in patients with respiratory failure. Besides this, ETTs have a crucial role in emergency, rapid-sequence intubation (RSI) to secure airways in cases of trauma, cardiac arrest, or unconsciousness (GCS < 8). In the case of pediatric & neonatal care, clinics are leveraging specialized, uncuffed tubes, particularly for premature babies or infants with respiratory obstruction.
In 2025, North America led the endotracheal tube market due to the rising cases of chronic obstructive pulmonary disease (COPD), bronchitis, & asthma. Also, the region has been stepping towards surging awareness and stringent protocols to prevent VAP, which results in higher use of advanced, most often single-use tubes. The region has implemented novel guidelines, i.e., 2025 Difficult Airway Society guidelines, which focus on video laryngoscopy as a first-line, superior tool to raise first-attempt success and lower complications.
U.S. Market Trends
Alongside, the U.S. was the largest contributor to the market, where numerous manufacturers are unveiling ETTs with united micro-sensors for real-time monitoring of cuff pressure, tracheal temperature, & locating to combat complications. Also, recently, a study has shown that ultrasound-guided subglottic diameter measurement is a rigorous method for selecting ETT sizes in children.
Asia Pacific is predicted to expand fastest in the endotracheal tube market, as it is experiencing a massive rise in geriatric populations, mainly in Japan, South Korea, and China, which leads to increased chronic disease prevalence. Besides this, consistent investment in ICU beds and in countries, including India and China, is impelling demand. More specifically, the Japanese government has widened investment in healthcare technology, such as airway management, with substantial allocations for advancing ICU infrastructure.
China Market Trends
However, certain Chinese manufacturers, such as Well Lead Medical and Shenzhen Huixinnuo Technology, are rising their market footprint with competitive pricing & enhanced quality in the sterile ETT area. Chinese researchers conducted a study of the analysis of 98 different ETTs from 7 brands, which has shown differentiations in Mark-Tip and Mark-Cuff distances across brands.
| Company | Description |
| Angiplast Pvt Ltd | This usually offers plain, cuffed, and reinforced variants to suit various clinical needs. |
| Advin Health Care | Its offerings include diverse endotracheal tubes and related respiratory training equipment. |
| Sterimed Group | A firm facilitates a comprehensive range of endotracheal (ET) tubes for airway management in general anaesthesia, intensive care, & emergency medicine. |
| ICU Medical, Inc. | This explores the Portex and Bivona brand endotracheal (ET) and tracheostomy tubes. |
| Medtronic (Covidien) | They offer their products under the Shiley (formerly Mallinckrodt) brand. |
| Van Oostveen Medical B.V. | It provides different, high-quality, CE-certified, and ISO 13485-qualified endotracheal tubes for safe, single-use, & short-term airway management in clinical environments. |
| Teleflex Incorporated | Its offerings are provided under Sheridan and Rüsch brands for both short- and long-term intubation across various clinical applications. |
| Convatec Inc. | This primarily offers various specialized endotracheal tubes (ET Tubes) for both adult and pediatric use. |
| Fuji Systems Corp | A firm specializes in high-quality silicone-based medical devices, specifically for anesthesiology & respiratory care. |
| SEWOON MEDICAL Co., Ltd. | It is a global manufacturer of medical devices, particularly in respiratory and tracheal tubes. |
By Product
By Route
By Application
By End Use
By Region
.webp)
Principal Consultant
Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.
Reviewed By
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.
March 2026
March 2026
March 2026
March 2026
sales@towardshealthcare.com
+1 804-441-9344
